Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway.

Autor: Li, Yeli, Feng, Linying, Xie, Dianyou, Lin, Mu, Li, Yiqi, Chen, Nana, Yang, Danli, Gao, Jianmei, Zhu, Yizhun, Gong, Qihai
Předmět:
Zdroj: Antioxidants; Aug2022, Vol. 11 Issue 8, pN.PAG-N.PAG, 18p
Abstrakt: Effect of ICS II on SIRT3-KO Mice To further verify if loss of functional SIRT3 offsets ICS II preconditioning-induced cardioprotection in MI, WT and SIRT3-KO mice were treated with or without ICS II for 7 days prior to MI. ICS II Mitigated MI-Induced Myocardial Injury in Mice The left anterior descending coronary artery ligation-induced MI mice model was used to determine the effect of ICS II on MI-induced myocardial injury. Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1 /Apoptosis Signaling Pathway ICS II Inhibited Myocardial Apoptosis in Mice after MI We next investigated the role of apoptosis in the inhibitory effect of ICS II on MI. [Extracted from the article]
Databáze: Complementary Index